TCL Archive NCI R01 Payline At 22nd Percentile, Plans To Cut Large R01 Budgets By 18 Percent. February 23, 2001
TCL Archive Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer November 20, 1992
TCL Archive Guest Editorial: A Near-Term Solution: NCI And COG Agree on Plan to Maintain Enrollment May 23, 2014
